Form 4: Tectonic Therapeutic Executive Marc Schwabish Reports Acquisition and Disposal of Shares
SEC Form 4 Filing
Chief Business Officer Marc Schwabish reports acquiring and disposing of Tectonic Therapeutic shares and stock options.
Summary
- On February 4, 2025, Marc Schwabish, Chief Business Officer of Tectonic Therapeutic, Inc., reported transactions involving the company's securities.
- Schwabish acquired 14,023 shares of common stock represented by restricted stock units at $0.
- Schwabish disposed of 4,700 shares of common stock.
- Following these transactions, Schwabish beneficially owns 18,723 shares of common stock.
- Schwabish also acquired an option to buy 25,496 shares of common stock at an exercise price of $48.01, exercisable in monthly installments starting March 4, 2025, and expiring on February 3, 2035.
- After the transaction, Schwabish directly owns 25,496 derivative securities.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Positives
- The acquisition of restricted stock units and stock options aligns the executive's interests with the long-term success of the company.
- The vesting schedules for both the restricted stock units and stock options incentivize continued service to the Issuer.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.
Comparison to Industry Standards
- Executive compensation packages often include stock options and restricted stock units to align management's interests with those of shareholders.
- Vesting schedules are a common mechanism to incentivize long-term commitment and performance.
Stakeholder Impact
- Shareholders can monitor insider transactions to gain insights into management's confidence in the company's prospects.
- The vesting schedules impact the executive's long-term compensation and incentives.
Key Dates
| Date | Description |
|---|---|
| 02/03/2035 | Expiration date of the Employee Stock Option. |
| 02/04/2025 | Date of transaction for common stock and employee stock option. |
| 02/04/2026 | First vesting date for restricted stock units. |
| 02/04/2027 | Second vesting date for restricted stock units. |
| 02/04/2028 | Third vesting date for restricted stock units. |
| 03/04/2025 | First monthly vesting date for the Employee Stock Option. |
| 02/06/2025 | Date of signature for the report. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.